Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 18, 2009 (rev. 1)

Premium

Simulations Plus has appointed John DiBella as manager of marketing and sales.

DiBella replaces Ronald Creeley, former vice president of marketing and sales, who is resigning as of the end of the month. He will report to Michael Pelekis, director of business development, marketing, and sales.

DiBella has been with Simulations Plus for over six years and developed the company's DDDPlus software for simulating in vitro dissolution experiments.

He holds a master’s degree in biomedical engineering from Case Western Reserve University.


Bill Hayden has joined life science informatics firm Praxeon as vice president of international business development.

Before joining the firm, he was head of international business development at IO Informatics and senior vice president at Coalesix.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.